Skip to main content

Peer Review reports

From: Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

Original Submission
18 Nov 2020 Submitted Original manuscript
6 Feb 2021 Reviewed Reviewer Report - Kirsty Loudon
7 Feb 2021 Reviewed Reviewer Report - Michael Joyner
11 Feb 2021 Author responded Author comments - Benjamin Gaborit
Resubmission - Version 2
11 Feb 2021 Submitted Manuscript version 2
13 Feb 2021 Editorially accepted
9 Mar 2021 Article published 10.1186/s13063-021-05132-9

You can find further information about peer review here.

Back to article page